Lilian Buch

Director, Reimbursement Strategy at Amgen

Speaker

Lilian Buch is Director, Reimbursement Strategy at Amgen. She leads strategies to anticipate and assess the impact of healthcare policies on patient access and reimbursement across a rare disease portfolio.

Lilian has over 20 years of experience in the pharmaceutical industry with expertise in commercial payer medical policy and utilization management, Medicare payment models, and impact of healthcare policy on patient access. Lilian has specifically focused on creating solutions and removing hurdles to optimize outcomes for patients and providers by supporting and executing access and reimbursement program strategies in oncology, rheumatology, and rare diseases.

Lilian earned a BA in biology from the University of Northern Iowa and is a Certified Professional Biller.